Trial intelligence / Profile preview

SLIT for Alternaria Allergic Rhinitis

NCT01127035Phase 4Completed

Sponsor
University of Genoa
Start
Jan 2006
Primary completion
Oct 2008
Modality
Allergy Immunotherapy
Countries
1
01

Overview

A Phase 4 trial of alternaria alternata allergen extract in allergic rhinitis (AR), sponsored by University of Genoa. Started Jan 2006; status: completed.

02

Drugs

alternaria alternata allergen extract
03

Conditions

allergic rhinitis (AR)

Beyond the preview

Go deeper on NCT01127035.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01127035.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call